Ezetimibe / Simvastatin Uses, Dosage, Side Effects and Interactions
Vytorin
Vytorin was the first ezetimibe / simvastatin product the FDA approved, in July 2004. An FDA-approved generic with the same active ingredients is listed.
Ezetimibe / Simvastatin is a two-in-one cholesterol medicine, taken as a tablet, that lowers LDL (“bad”) cholesterol in people with high cholesterol, including inherited forms, alongside a healthy diet.
Quick links
Ask Anything About Ezetimibe / SimvastatinType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Ezetimibe / Simvastatin in Short
- Drug classes Dietary Cholesterol Absorption Inhibitor; HMG-CoA Reductase Inhibitor How the FDA classifies it
What it treatsEzetimibe / Simvastatin is used along with a cholesterol-lowering diet to bring down high cholesterol (primary hyperlipidemia and mixed hyperlipidemia). It is also used for inherited high cholesterol (familial hypercholesterolemia).
- How you get it Prescription only
- Comes asTablet (by mouth)Available strengths (ezetimibe/simvastatin)
- 10 mg/10 mg
- 10 mg/20 mg
- 10 mg/40 mg
- 10 mg/80 mg
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- What pharmacies pay
- Generic$0.18 to $0.27 a tablet
- Vytorin (brand)$13.71 to $13.80 a tablet
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Ezetimibe/simvastatin (Vytorin) lowers LDL (“bad”) cholesterol, including in inherited forms of high cholesterol, by pairing ezetimibe, which blocks cholesterol absorption in the gut, with simvastatin, a statin that slows the liver’s own cholesterol production; it is usually an add-on step when a statin alone falls short, on the U.S. market since about 2004 with FDA-approved generics listed. Most people tolerate it well, and the side effects noticed most are headache, muscle aches and diarrhea. The one thing to watch for is unexplained muscle pain, tenderness or weakness, especially with fever, since it can rarely signal rhabdomyolysis, a serious muscle breakdown that can harm the kidneys.
Key Takeaways From the HelloPharmacist Team
- Take it once each evening, with or without food; a missed dose is taken when remembered, never doubled.
- Avoid grapefruit juice and have every new prescription checked against it; some antibiotics, antifungals and heart medicines clash or require a lower dose.
- Expect a liver blood test before starting and later as needed, and report yellowing of the skin or eyes promptly.
- Use effective birth control if you could become pregnant, and stop it and call your prescriber right away if pregnancy happens.
Patient Information Guide for Ezetimibe / Simvastatin
What It’s Used For
Ezetimibe / Simvastatin is used with diet to lower cholesterol.
- Primary hyperlipidemia (high cholesterol), and mixed hyperlipidemia on the Ezetimibe and Simvastatin tablet label
- Heterozygous familial hypercholesterolemia: Vytorin is approved for adults and children aged 10 and older
- Homozygous familial hypercholesterolemia, as an add-on to other cholesterol-lowering treatments
- Vytorin: lowering the risk of death, heart attack, stroke and artery-opening procedures in adults at high risk of coronary heart disease events (with coronary heart disease, cerebrovascular disease, peripheral vascular disease and/or diabetes)
How It Works
Cholesterol in your blood comes from food absorbed in the gut and from the liver’s own production. Ezetimibe blocks a transporter in the small intestine that takes up cholesterol. This means less cholesterol reaches the liver.
Simvastatin blocks HMG-CoA reductase, a liver enzyme needed to make cholesterol. The liver then pulls more LDL cholesterol out of the blood. Together they lower LDL cholesterol through two complementary routes.
Drug Class
Drug Class
- Dietary Cholesterol Absorption Inhibitor from ezetimibe
- HMG-CoA Reductase Inhibitor from simvastatin
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Ezetimibe / Simvastatin has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- Dietary Cholesterol Absorption Inhibitor from ezetimibe
- HMG-CoA Reductase Inhibitor from simvastatin
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Hydroxymethylglutaryl-CoA Reductase Inhibitors from simvastatin
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)- Decreased Cholesterol Absorption from ezetimibe
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Ezetimibe / Simvastatin in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Combinations of various lipid modifying agents
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
The tablet is taken by mouth once a day in the evening, with or without food. Your prescriber picks the strength, and your cholesterol is usually rechecked a few weeks after starting or changing the dose.
- If you miss a dose (Vytorin), take it as soon as you can. Do not double the next dose.
- Take it at least 2 hours before or 4 hours after a bile acid sequestrant.
- Some medicines you take can limit your dose.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
High cholesterol
Adults Usual dose 10/10 mg to 10/40 mg once a day Highest dose 10/40 mg once daily
- Vytorin 10/10 mg to 10/40 mg once a day, taken orally in the evening with or without food
Good to know
Vytorin 10/80 mg daily is restricted to patients who have taken it chronically (e.g., for 12 months or more) without evidence of muscle toxicity
Children 10 years and older Usual dose 10/10 mg to 10/40 mg once a day Highest dose 10/40 mg once daily
- Vytorin 10/10 mg to 10/40 mg once a day
Adults with moderate to severe kidney problems Doses of Vytorin exceeding 10/20 mg should be used with caution and close monitoring
Good to know
No dosage adjustment recommendations for mild renal impairment
Special Situations
Patients taking lomitapide
Reduce the dosage of Vytorin by 50%
Patients taking verapamil, diltiazem, or dronedarone
Do not exceed Vytorin 10/10 mg once daily
Patients taking amiodarone, amlodipine, or ranolazine
Do not exceed Vytorin 10/20 mg once daily
Side Effects
Common side effects seen in studies include:
Common side effects
- Headache
- Increased liver enzyme (ALT) on blood tests
- Muscle aches (myalgia)
- Upper respiratory tract infection
- Diarrhea
- Pain in arms or legs
- Flu
When to get medical help
- Call your doctor promptly if you have unexplained muscle pain, tenderness or weakness, especially with fever or feeling unwell. This could be myopathy or rhabdomyolysis (serious muscle breakdown).
- Get help if you have signs of liver problems such as yellowing of the skin or eyes (jaundice).
- Seek urgent care for allergic reactions such as swelling of the face or throat, hives, or trouble breathing.
- Tell your doctor if muscle weakness continues even after stopping the medicine.
- Let your doctor know about memory loss or confusion, which has been reported rarely with statins and is generally reversible after stopping.
- If you become pregnant, stop the medicine and call your doctor right away.
Warnings and Precautions
- Muscle damage: myopathy and rhabdomyolysis are the main risks and rise with higher doses. The 10/80 strength is restricted to people who have long tolerated it.
- Higher risk groups: age 65 and older, women, uncontrolled underactive thyroid, kidney problems and possibly Chinese patients.
- Liver: enzymes can rise, and testing is advised before starting and as needed. Rare liver failure has been reported with statins.
- Immune-mediated necrotizing myopathy: a rare autoimmune muscle condition linked to statins, with weakness that persists after stopping.
- Your doctor may pause the medicine during serious illness, major surgery or trauma.
Interactions
Many medicines raise simvastatin levels and muscle risk, so always check before starting anything new.
- Strong CYP3A4 inhibitors (certain antifungals, antibiotics, HIV medicines, nefazodone): not allowed with this medicine
- Gemfibrozil, cyclosporine, danazol: not allowed
- Grapefruit juice: avoid it
- Verapamil, diltiazem, dronedarone, amiodarone, amlodipine, ranolazine: dose limits apply
- Fenofibrates, niacin, colchicine: higher muscle risk, so monitoring is needed
- Daptomycin: this medicine is usually paused temporarily
- Lomitapide: dose is reduced
- Bile acid sequestrants: space doses apart so ezetimibe works
- Warfarin-type blood thinners and digoxin: blood tests are monitored
Interactions Listed in the FDA-Approved Label
From the Ezetimibe / Simvastatin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Strong CYP3A4 inhibitors For example: itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, nelfinavir, ritonavir, boceprevir, telaprevir, cobicistat-containing products, nefazodoneWhat happensIncreases simvastatin exposure and the risk of myopathy and rhabdomyolysis.What to doContraindicated; if treatment with a CYP3A4 inhibitor is unavoidable, suspend ezetimibe and simvastatin during the course of treatment.
-
Cyclosporine, danazol, or gemfibrozilWhat happensThe risk of myopathy and rhabdomyolysis is increased.What to doConcomitant use is contraindicated.
-
Amiodarone, dronedarone, ranolazine, or calcium channel blockersWhat happensThe risk of myopathy and rhabdomyolysis is increased.What to doWith verapamil, diltiazem, or dronedarone do not exceed 10/10 mg daily; with amiodarone, amlodipine, or ranolazine do not exceed 10/20 mg daily.
-
What happensSimvastatin exposure is approximately doubled and the risk of myopathy and rhabdomyolysis is increased.What to doReduce the dose by 50% if initiating lomitapide; do not exceed 10/20 mg daily (or 10/40 mg daily for patients who previously took 10/80 mg chronically).
-
DaptomycinWhat happensCases of rhabdomyolysis reported; both can cause myopathy and rhabdomyolysis, and risk may be increased by coadministration.What to doIf daptomycin is required, consider temporarily suspending ezetimibe and simvastatin during daptomycin treatment.
-
What happensCases of myopathy and rhabdomyolysis have been observed; the risk of myopathy is greater in Chinese patients.What to doNot recommended in Chinese patients; for others, consider whether benefit outweighs risk and monitor for signs and symptoms of myopathy.
-
Fibrates (other than gemfibrozil)What happensThe risk of myopathy and rhabdomyolysis is increased.What to doConsider if benefit outweighs risk; if used together, monitor for signs and symptoms of myopathy.
-
What happensCases of myopathy and rhabdomyolysis have been reported.What to doConsider if benefit outweighs risk; if used together, monitor for signs and symptoms of myopathy.
-
Grapefruit juiceWhat happensCan raise plasma levels of simvastatin and may increase the risk of myopathy and rhabdomyolysis.What to doAvoid grapefruit juice when taking ezetimibe and simvastatin.
-
Bile acid sequestrants (cholestyramine)What happensCholestyramine decreased mean exposure of total ezetimibe approximately 55%, which may reduce the incremental LDL-C reduction.What to doAdminister ezetimibe and simvastatin at least 2 hours before or at least 4 hours after the bile acid sequestrant.
Read the label’s full interactions text
7 DRUG INTERACTIONS Ezetimibe and simvastatin tablets • See full prescribing information for details regarding concomitant use of ezetimibe and simvastatin tablets with other drugs or grapefruit juice that increase the risk of myopathy and rhabdomyolysis. • Cholestyramine: Combination decreases exposure of ezetimibe. • Coumarin Anticoagulants: Obtain INR before ezetimibe and simvastatin tablets initiation and monitor INR during ezetimibe and simvastatin tablets dosage initiation or adjustment. • Digoxin: During ezetimibe and simvastatin tablets initiation, monitor digoxin levels. • Fenofibrates: Combination increases exposure of ezetimibe. If cholelithiasis is suspected in a patient receiving ezetimibe and a fenofibrate, gallbladder studies are indicated and alternative lipid-lowering therapy should be considered. 7.1 Drug Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with Ezetimibe and Simvastatin Tablets Ezetimibe and simvastatin tablets are a substrate of CYP3A4 and of the transport protein OATP1B1. ezetimibe and simvastatin tablets plasma levels can be significantly increased with concomitant administration of inhibitors of CYP3A4 and OATP1B1. Table 2 includes a list of drugs that increase the risk of myopathy and rhabdomyolysis when used concomitantly with ezetimibe and simvastatin tablets and instructions for preventing or managing them. Table 2: Drug Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with Ezetimibe and Simvastatin Tablets Strong CYP3A4 inhibitors Clinical Impact: Simvastatin is a substrate of CYP3A4. Concomitant use of strong CYP3A4 inhibitors with ezetimibe and simvastatin tablets increases simvastatin exposure and increases the risk of myopathy and rhabdomyolysis, particularly with higher ezetimibe and simvastatin tablets dosages.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use during pregnancy or if you may become pregnant. Use effective contraception, and stop right away if you become pregnant.
- Do not use while breastfeeding.
- Do not use with active liver disease or unexplained persistent liver enzyme elevations.
- Do not use if allergic to any ingredient.
- Older adults (65+) should use it with caution because of muscle risk.
- With moderate to severe kidney problems, higher doses need caution and close monitoring.
- Children: Vytorin is approved for ages 10 and up with heterozygous familial hypercholesterolemia.
- Tell your doctor if you drink substantial amounts of alcohol.
Overdose
No specific treatment for overdose is recommended. Care focuses on treating symptoms and supportive measures. A few overdoses have been reported with the individual ingredients, and those people recovered without lasting effects. If you take too much, call Poison Control or seek medical help.
Half-Life and How Your Body Processes It
The combination tablet was shown to match taking ezetimibe and simvastatin as separate tablets. Ezetimibe is absorbed and converted to an active form, and its half-life is about 22 hours. Food does not change how much ezetimibe is absorbed. Simvastatin is largely cleared by the liver on first pass, and food does not affect it much. Both are mostly removed through feces, with some leaving in urine. Levels are higher in older adults.
Storage
Store at 68°F to 77°F (20°C to 25°C).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ezetimibe / Simvastatin: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Ezetimibe / Simvastatin — the kind of thing our pharmacy team would talk through with you at the counter.
What is this medicine for?
When and how should I take it?
What side effects should I expect?
When should I call my doctor?
Can I drink grapefruit juice or take other medicines with it?
Is it safe in pregnancy?
Is ezetimibe / simvastatin available over the counter?
When was ezetimibe / simvastatin first available?
Who makes ezetimibe / simvastatin?
What is the brand name of ezetimibe / simvastatin?
What is the generic name of Vytorin?
What drug class is ezetimibe / simvastatin?
Is there a generic version of ezetimibe / simvastatin?
What strengths does ezetimibe / simvastatin come in?
How much does ezetimibe / simvastatin cost?
Where can I read the ezetimibe / simvastatin prescribing information (package insert)?
Is ezetimibe / simvastatin gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Ezetimibe / Simvastatin
Skip the scrolling. Ask in your own words and get an answer from Ezetimibe / Simvastatin’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Ezetimibe / Simvastatin’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Ezetimibe / Simvastatin on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Ezetimibe / Simvastatin Forms and Strengths (How It Comes)
Ezetimibe / Simvastatin comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Ezetimibe / Simvastatin inactive ingredients by manufacturer.
Tablet
How this form is used
- Ezetimibe and Simvastatin tablets are used with diet to lower cholesterol in primary or mixed hyperlipidemia and in homozygous familial hypercholesterolemia.
- Vytorin is used to lower LDL cholesterol in adults with primary hyperlipidemia and in adults and children 10 and older with heterozygous familial hypercholesterolemia.
- Vytorin is also used with other LDL-lowering treatments in adults with homozygous familial hypercholesterolemia.
- Vytorin is taken by mouth once daily in the evening, with or without food.
- Ezetimibe and Simvastatin tablets are taken as a single daily dose in the evening, with or without food.
- Vytorin: if you miss a dose, take it as soon as possible and do not double the next dose.
- Vytorin and Ezetimibe and Simvastatin tablets should be taken at least 2 hours before or 4 hours after a bile acid sequestrant.
Ezetimibe / Simvastatin on the U.S. Market: Products, Makers and Brands
How Ezetimibe / Simvastatin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
8 companies list 27 Ezetimibe / Simvastatin product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2004. The one brand name in the directory today is Vytorin; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished tablet (8) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Ezetimibe / Simvastatin Is Used (Medicaid Data)
How many Ezetimibe / Simvastatin prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Ezetimibe / Simvastatin prescribed? Of the 1,682 medications we measure, Ezetimibe / Simvastatin ranks #1,145 by Medicaid prescriptions — more than 32% of them.
Utilization by Ezetimibe / Simvastatin product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
ezetimibe 10 MG / simvastatin 20 MG Oral Tablet Most dispensed
4 of 39 listed NDCs had Medicaid claims. RxNorm 476349
ezetimibe 10 MG / simvastatin 40 MG Oral Tablet
6 of 40 listed NDCs had Medicaid claims. RxNorm 476350
ezetimibe 10 MG / simvastatin 10 MG Oral Tablet
3 of 36 listed NDCs had Medicaid claims. RxNorm 476345
ezetimibe 10 MG / simvastatin 80 MG Oral Tablet
2 of 35 listed NDCs had Medicaid claims. RxNorm 476351
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 15 of the 150 listed Ezetimibe / Simvastatin NDCs had Medicaid claims.
Compare Ezetimibe / Simvastatin Products
A representative set of FDA-listed product records for Ezetimibe / Simvastatin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 80 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 80 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg | Oral | Dr.Reddys Laboratories Inc | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg | Oral | Dr.Reddys Laboratories Inc | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg | Oral | Dr.Reddys Laboratories Inc | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 80 mg | Oral | Dr.Reddys Laboratories Inc | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 80 mg | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 80 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 80 mg | Oral | Northstar Rx Llc | ANDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg | Oral | Organon LLC | NDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg | Oral | Organon LLC | NDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg | Oral | Organon LLC | NDA | View NDC → |
| EZETIMIBE 10 mg/1; SIMVASTATIN 80 mg | Oral | Organon LLC | NDA | View NDC → |
Showing 27 of 27 products — FDA National Drug Code Directory. See every product, package size and price: browse all 27 Ezetimibe / Simvastatin NDCs →
Ezetimibe / Simvastatin Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ezetimibe / Simvastatin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ezetimibe / Simvastatin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Ezetimibe / Simvastatin FDA Approval History
How Ezetimibe / Simvastatin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Ezetimibe / Simvastatin Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Ezetimibe / Simvastatin recalls since July 2021.
✅No Ezetimibe / Simvastatin recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Ezetimibe / Simvastatin in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.
- Dose forms
- 1
- Strengths
- 4
- Forms in current FDA listings
- 1 of 1
RxCUI 484211 -
Dose form (SCDF) Oral TabletIn current FDA listings
RxCUI 476348Its 4 strengths (SCD)-
ezetimibe 10 mg / simvastatin 10 mg
RxCUI 476345 -
ezetimibe 10 mg / simvastatin 20 mg
RxCUI 476349 -
ezetimibe 10 mg / simvastatin 40 mg
RxCUI 476350 -
ezetimibe 10 mg / simvastatin 80 mg
RxCUI 476351
-
ezetimibe 10 mg / simvastatin 10 mg
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Ezetimibe / Simvastatin Supply and Shortage Status
Whether Ezetimibe / Simvastatin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Ezetimibe / Simvastatin Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Ezetimibe / Simvastatin: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick the generic or the brand and a strength to see how its price has changed since Nov 2023.
For the generic EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg tablet, pharmacies paid an average of $0.224 per tablet as of Nov 18, 2026, down 31% from $0.325 a year earlier.
- What pharmacies pay now
- $0.224
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- Down 15%
- from $0.265 on Oct 21, 2026
- Last 12 months
- Down 31%
- from $0.325 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $0.224 to $0.574
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.224 |
| Oct 2026 | $0.265 |
| Sep 2026 | $0.274 |
| Aug 2026 | $0.328 |
| Jul 2026 | $0.359 |
| Jun 2026 | $0.381 |
| May 2026 | $0.350 |
| Apr 2026 | $0.327 |
| Mar 2026 | $0.345 |
| Feb 2026 | $0.366 |
| Jan 2026 | $0.353 |
| Dec 2025 | $0.335 |
| Nov 2025 | $0.325 |
| Oct 2025 | $0.319 |
| Sep 2025 | $0.303 |
| Aug 2025 | $0.264 |
| Jul 2025 | $0.280 |
| Jun 2025 | $0.304 |
| May 2025 | $0.350 |
| Apr 2025 | $0.331 |
| Mar 2025 | $0.334 |
| Feb 2025 | $0.325 |
| Jan 2025 | $0.340 |
| Dec 2024 | $0.379 |
| Nov 2024 | $0.323 |
| Oct 2024 | $0.456 |
| Sep 2024 | $0.419 |
| Aug 2024 | $0.301 |
| Jul 2024 | $0.308 |
| Jun 2024 | $0.374 |
| May 2024 | $0.323 |
| Apr 2024 | $0.380 |
| Mar 2024 | $0.444 |
| Feb 2024 | $0.383 |
| Jan 2024 | $0.493 |
| Dec 2023 | $0.427 |
| Nov 2023 | $0.574 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | EZETIMIBE 10 mg/1; SIMVASTATIN 10 mg | Generic | $0.224 per tablet | NDC details & price history |
| Tablet · Oral | EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg | Generic | $0.181 per tablet | NDC details & price history |
| Tablet · Oral | EZETIMIBE 10 mg/1; SIMVASTATIN 20 mg | Vytorin (brand) | $13.71 per tablet | NDC details & price history |
| Tablet · Oral | EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg | Generic | $0.196 per tablet | NDC details & price history |
| Tablet · Oral | EZETIMIBE 10 mg/1; SIMVASTATIN 40 mg | Vytorin (brand) | $13.80 per tablet | NDC details & price history |
| Tablet · Oral | EZETIMIBE 10 mg/1; SIMVASTATIN 80 mg | Generic | $0.236–$0.273 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Ezetimibe / Simvastatin Brand Names
Ezetimibe / Simvastatin has one brand name on record: Vytorin. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Ezetimibe / Simvastatin: Manufacturers and Labelers
8 companies list Ezetimibe / Simvastatin products with the FDA. By number of product records, the largest are Ascend Laboratories, LLC, Aurobindo Pharma Limited, Dr.Reddys Laboratories Inc. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Ezetimibe / Simvastatin Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Organon LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →